These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

186 related items for PubMed ID: 25152372

  • 1. miR-133 is a key negative regulator of CDC42-PAK pathway in gastric cancer.
    Cheng Z, Liu F, Wang G, Li Y, Zhang H, Li F.
    Cell Signal; 2014 Dec; 26(12):2667-73. PubMed ID: 25152372
    [Abstract] [Full Text] [Related]

  • 2. miR-148b-3p inhibits gastric cancer metastasis by inhibiting the Dock6/Rac1/Cdc42 axis.
    Li X, Jiang M, Chen D, Xu B, Wang R, Chu Y, Wang W, Zhou L, Lei Z, Nie Y, Fan D, Shang Y, Wu K, Liang J.
    J Exp Clin Cancer Res; 2018 Mar 27; 37(1):71. PubMed ID: 29587866
    [Abstract] [Full Text] [Related]

  • 3. miR-185 targets RhoA and Cdc42 expression and inhibits the proliferation potential of human colorectal cells.
    Liu M, Lang N, Chen X, Tang Q, Liu S, Huang J, Zheng Y, Bi F.
    Cancer Lett; 2011 Feb 28; 301(2):151-60. PubMed ID: 21186079
    [Abstract] [Full Text] [Related]

  • 4. miR-330 regulates the proliferation of colorectal cancer cells by targeting Cdc42.
    Li Y, Zhu X, Xu W, Wang D, Yan J.
    Biochem Biophys Res Commun; 2013 Feb 15; 431(3):560-5. PubMed ID: 23337504
    [Abstract] [Full Text] [Related]

  • 5. miR-137 targets Cdc42 expression, induces cell cycle G1 arrest and inhibits invasion in colorectal cancer cells.
    Liu M, Lang N, Qiu M, Xu F, Li Q, Tang Q, Chen J, Chen X, Zhang S, Liu Z, Zhou J, Zhu Y, Deng Y, Zheng Y, Bi F.
    Int J Cancer; 2011 Mar 15; 128(6):1269-79. PubMed ID: 20473940
    [Abstract] [Full Text] [Related]

  • 6. miR-29a-3p inhibits endometrial cancer cell proliferation, migration and invasion by targeting VEGFA/CD C42/PAK1.
    Geng A, Luo L, Ren F, Zhang L, Zhou H, Gao X.
    BMC Cancer; 2021 Jul 21; 21(1):843. PubMed ID: 34289832
    [Abstract] [Full Text] [Related]

  • 7. MiR-29a inhibits cell proliferation and migration by targeting the CDC42/PAK1 signaling pathway in cervical cancer.
    Chen R, Zhang L.
    Anticancer Drugs; 2019 Jul 21; 30(6):579-587. PubMed ID: 30724771
    [Abstract] [Full Text] [Related]

  • 8. MiR-145, miR-133a and miR-133b inhibit proliferation, migration, invasion and cell cycle progression via targeting transcription factor Sp1 in gastric cancer.
    Qiu T, Zhou X, Wang J, Du Y, Xu J, Huang Z, Zhu W, Shu Y, Liu P.
    FEBS Lett; 2014 Apr 02; 588(7):1168-77. PubMed ID: 24613927
    [Abstract] [Full Text] [Related]

  • 9. MiR-384 inhibits human colorectal cancer metastasis by targeting KRAS and CDC42.
    Wang YX, Chen YR, Liu SS, Ye YP, Jiao HL, Wang SY, Xiao ZY, Wei WT, Qiu JF, Liang L, Liao WT, Ding YQ.
    Oncotarget; 2016 Dec 20; 7(51):84826-84838. PubMed ID: 27769041
    [Abstract] [Full Text] [Related]

  • 10. miR-124 interacts with the Notch1 signalling pathway and has therapeutic potential against gastric cancer.
    Jiang L, Lin T, Xu C, Hu S, Pan Y, Jin R.
    J Cell Mol Med; 2016 Feb 20; 20(2):313-22. PubMed ID: 26612211
    [Abstract] [Full Text] [Related]

  • 11. miR-130b directly targets ARHGAP1 to drive activation of a metastatic CDC42-PAK1-AP1 positive feedback loop in Ewing sarcoma.
    Satterfield L, Shuck R, Kurenbekova L, Allen-Rhoades W, Edwards D, Huang S, Rajapakshe K, Coarfa C, Donehower LA, Yustein JT.
    Int J Cancer; 2017 Nov 15; 141(10):2062-2075. PubMed ID: 28748534
    [Abstract] [Full Text] [Related]

  • 12. Effects of microRNA-29 family members on proliferation and invasion of gastric cancer cell lines.
    Lang N, Liu M, Tang QL, Chen X, Liu Z, Bi F.
    Chin J Cancer; 2010 Jun 15; 29(6):603-10. PubMed ID: 20507733
    [Abstract] [Full Text] [Related]

  • 13. MicroRNA‑195 suppresses cell proliferation, migration and invasion in epithelial ovarian carcinoma via inhibition of the CDC42/CCND1 pathway.
    Hao X, Jia Q, Yuan J, Shi X, Guo H, Gao J, Guo Y.
    Int J Mol Med; 2020 Nov 15; 46(5):1862-1872. PubMed ID: 32901852
    [Abstract] [Full Text] [Related]

  • 14. Reduced miR-125a-5p expression is associated with gastric carcinogenesis through the targeting of E2F3.
    Xu Y, Huang Z, Liu Y.
    Mol Med Rep; 2014 Nov 15; 10(5):2601-8. PubMed ID: 25231560
    [Abstract] [Full Text] [Related]

  • 15. miR-18a inhibits CDC42 and plays a tumour suppressor role in colorectal cancer cells.
    Humphreys KJ, McKinnon RA, Michael MZ.
    PLoS One; 2014 Nov 15; 9(11):e112288. PubMed ID: 25379703
    [Abstract] [Full Text] [Related]

  • 16. The novel GINS4 axis promotes gastric cancer growth and progression by activating Rac1 and CDC42.
    Zhu Z, Yu Z, Rong Z, Luo Z, Zhang J, Qiu Z, Huang C.
    Theranostics; 2019 Nov 15; 9(26):8294-8311. PubMed ID: 31754397
    [Abstract] [Full Text] [Related]

  • 17. miR-7 inhibits the invasion and metastasis of gastric cancer cells by suppressing epidermal growth factor receptor expression.
    Xie J, Chen M, Zhou J, Mo MS, Zhu LH, Liu YP, Gui QJ, Zhang L, Li GQ.
    Oncol Rep; 2014 Apr 15; 31(4):1715-22. PubMed ID: 24573489
    [Abstract] [Full Text] [Related]

  • 18. Downregulation of miR-101 in gastric cancer correlates with cyclooxygenase-2 overexpression and tumor growth.
    He XP, Shao Y, Li XL, Xu W, Chen GS, Sun HH, Xu HC, Xu X, Tang D, Zheng XF, Xue YP, Huang GC, Sun WH.
    FEBS J; 2012 Nov 15; 279(22):4201-12. PubMed ID: 23013439
    [Abstract] [Full Text] [Related]

  • 19. Deregulated expression of miR-145 in manifold human cancer cells.
    Xing AY, Wang B, Shi DB, Zhang XF, Gao C, He XQ, Liu WJ, Gao P.
    Exp Mol Pathol; 2013 Aug 15; 95(1):91-7. PubMed ID: 23714355
    [Abstract] [Full Text] [Related]

  • 20. Group I p21-activated kinases (PAKs) promote tumor cell proliferation and survival through the AKT1 and Raf-MAPK pathways.
    Menges CW, Sementino E, Talarchek J, Xu J, Chernoff J, Peterson JR, Testa JR.
    Mol Cancer Res; 2012 Sep 15; 10(9):1178-88. PubMed ID: 22798428
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.